Lingjun Wang
Impact in
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- Inflammasome and immune disorders 4
-
- Cardiac Fibrosis and Remodeling 10
- Co-authors
- Shaoxiang Xian (27 shared papers)Yu‐Sheng Huang (26 shared papers)Lu Lu (30 shared papers)Zhongqi Yang (19 shared papers)Lu Zhang (7 shared papers)Junyan Wang (9 shared papers)Birong Liang (6 shared papers)Huan Li (15 shared papers)
- Journals
- Phytomedicine (7 papers)Sustainability (4 papers)Journal of Ethnopharmacology (4 papers)Cell Death and Disease (3 papers)Evidence-based Complementary and Alternative Medicine (3 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lingjun Wang
97 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 143
- Clinical Biochemistry 88
- Cancer Research 141
- Cardiology and Cardiovascular Medicine 161
- Immunology 156
- Nephrology 48
Countries citing papers authored by Lingjun Wang
This map shows the geographic impact of Lingjun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjun Wang more than expected).
Fields of papers citing papers by Lingjun Wang
This network shows the impact of papers produced by Lingjun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjun Wang. The network helps show where Lingjun Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingjun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 103 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 177 | |
| 2 | 2019 | 79 | |
| 3 | 2021 | 73 | |
| 4 | 2009 | 63 | |
| 5 | 2021 | 50 | |
| 6 | 2017 | 49 | |
| 7 | 2021 | 44 | |
| 8 | 2022 | 42 | |
| 9 | 2018 | 39 | |
| 10 | 2022 | 36 | |
| 11 | 2021 | 34 | |
| 12 | 2022 | 31 | |
| 13 | 2002 | 27 | |
| 14 | 2019 | 27 | |
| 15 | 2017 | 27 | |
| 16 | 2018 | 25 | |
| 17 | 2023 | 25 | |
| 18 | 2020 | 24 | |
| 19 | 2022 | 24 | |
| 20 | 2023 | 23 |
About Lingjun Wang
Lingjun Wang is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Pollution, Epidemiology and Environmental Engineering, having authored 103 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cardiac Fibrosis and Remodeling (10 papers), Autophagy in Disease and Therapy (6 papers), Photovoltaic Systems and Sustainability (5 papers), Advanced Glycation End Products research (5 papers), Energy and Environment Impacts (5 papers), Inflammasome and immune disorders (4 papers), Macrophage Migration Inhibitory Factor (3 papers) and Bone Tissue Engineering Materials (3 papers). The work is most often cited by research in Clinical Biochemistry (88 citations), Cancer Research (141 citations), Cardiology and Cardiovascular Medicine (161 citations), Immunology (156 citations) and Nephrology (48 citations). Lingjun Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Shaoxiang Xian, Yu‐Sheng Huang, Lu Lu, Zhongqi Yang, Lu Zhang, Junyan Wang, Birong Liang, Huan Li, Chen Jian and Zixin Chen. Their work appears in journals such as Phytomedicine, Sustainability, Journal of Ethnopharmacology, Cell Death and Disease and Evidence-based Complementary and Alternative Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.